CureVac’s (CVAC) “Market Outperform” Rating Reaffirmed at JMP Securities
JMP Securities reaffirmed their market outperform rating on shares of CureVac (NASDAQ:CVAC – Free Report) in a research note published on Monday morning, Benzinga reports. They currently have a $16.00 price objective on the stock. CureVac Price Performance CureVac stock opened at $3.29 on Monday. The stock has a market cap of $736.57 million, a […]
More Stories
Boliden AB (publ) (OTCMKTS:BDNNY) Lifted to “Hold” at Berenberg Bank
Berenberg Bank upgraded shares of Boliden AB (publ) (OTCMKTS:BDNNY – Free Report) to a hold rating in a report issued...
Telia Company AB (publ) (OTCMKTS:TLSNY) Upgraded at BNP Paribas
BNP Paribas upgraded shares of Telia Company AB (publ) (OTCMKTS:TLSNY – Free Report) to a strong-buy rating in a research...
Telia Company AB (publ) (OTCMKTS:TLSNY) Upgraded at BNP Paribas
BNP Paribas upgraded shares of Telia Company AB (publ) (OTCMKTS:TLSNY – Free Report) to a strong-buy rating in a report...
General Mills (NYSE:GIS) Announces Earnings Results
General Mills (NYSE:GIS – Get Free Report) issued its earnings results on Wednesday. The company reported $1.07 earnings per share...
When is ‘Skull Island’ Season 2 coming? Know Everything Here!
Netflix has officially finalized the screenplays for Skull Island season 2. Originating in Legendary’s Monsterverse, Skull Island premiered a few...
Analysts Set Bausch Health Companies Inc. (NYSE:BHC) Price Target at $7.33
Bausch Health Companies Inc. (NYSE:BHC – Get Free Report) has received a consensus recommendation of “Hold” from the six research...